Koenders MI - Search Results

1

Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease.

Maicas N, Ferrándiz ML, Brines R, Ibáñez L, Cuadrado A, Koenders MI, van den Berg WB, Alcaraz MJ. Maicas N, et al. Among authors: koenders mi. Antioxid Redox Signal. 2011 Aug 15;15(4):889-901. doi: 10.1089/ars.2010.3835. Epub 2011 May 25. Antioxid Redox Signal. 2011. PMID: 21406003 Free article.

2

The CO-releasing molecule CORM-3 protects against articular degradation in the K/BxN serum transfer arthritis model.

Maicas N, Ferrándiz ML, Devesa I, Motterlini R, Koenders MI, van den Berg WB, Alcaraz MJ. Maicas N, et al. Among authors: koenders mi. Eur J Pharmacol. 2010 May 25;634(1-3):184-91. doi: 10.1016/j.ejphar.2010.02.028. Epub 2010 Feb 23. Eur J Pharmacol. 2010. PMID: 20184873

3

Up-regulation of the inflammatory response by ovariectomy in collagen-induced arthritis. effects of tin protoporphyrin IX.

Ibáñez L, Alcaraz MJ, Maicas N, Guede D, Caeiro JR, Koenders MI, van den Berg WB, Ferrándiz ML. Ibáñez L, et al. Among authors: koenders mi. Inflammation. 2011 Dec;34(6):585-96. doi: 10.1007/s10753-010-9266-4. Inflammation. 2011. PMID: 21046213

4

Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.

Koenders MI, Joosten LA, van den Berg WB. Koenders MI, et al. Ann Rheum Dis. 2006 Nov;65 Suppl 3(Suppl 3):iii29-33. doi: 10.1136/ard.2006.058529. Ann Rheum Dis. 2006. PMID: 17038468 Free PMC article. Review.

5

The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.

Lubberts E, Koenders MI, van den Berg WB. Lubberts E, et al. Among authors: koenders mi. Arthritis Res Ther. 2005;7(1):29-37. doi: 10.1186/ar1478. Epub 2004 Nov 30. Arthritis Res Ther. 2005. PMID: 15642151 Free PMC article. Review.

6

Novel therapeutic targets in rheumatoid arthritis.

Koenders MI, van den Berg WB. Koenders MI, et al. Trends Pharmacol Sci. 2015 Apr;36(4):189-95. doi: 10.1016/j.tips.2015.02.001. Epub 2015 Feb 27. Trends Pharmacol Sci. 2015. PMID: 25732812 Review.

7

Secukinumab for rheumatology: development and its potential place in therapy.

Koenders MI, van den Berg WB. Koenders MI, et al. Drug Des Devel Ther. 2016 Jun 24;10:2069-80. doi: 10.2147/DDDT.S105263. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27445458 Free PMC article. Review.

8

Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity?

Koenders MI, van den Berg WB. Koenders MI, et al. Clin Exp Immunol. 2010 Feb;159(2):131-6. doi: 10.1111/j.1365-2249.2009.04039.x. Epub 2009 Nov 11. Clin Exp Immunol. 2010. PMID: 19912250 Free PMC article. Review.

9

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB. Lubberts E, et al. Among authors: koenders mi. Arthritis Rheum. 2004 Feb;50(2):650-9. doi: 10.1002/art.20001. Arthritis Rheum. 2004. PMID: 14872510 Free article.

10

Amplifying elements of arthritis and joint destruction.

van den Berg WB, van Lent PL, Joosten LA, Abdollahi-Roodsaz S, Koenders MI. van den Berg WB, et al. Among authors: koenders mi. Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii45-8. doi: 10.1136/ard.2007.079830. Ann Rheum Dis. 2007. PMID: 17934095 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page